Gene: ABLIM2
Official Full Name: actin binding LIM protein family member 2provided by HGNC
Gene Summary: Predicted to enable actin filament binding activity. Predicted to be involved in lamellipodium assembly. Predicted to act upstream of or within positive regulation of transcription by RNA polymerase II. Located in actin cytoskeleton. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO24873 | ABLIM2 Knockout cell line (HeLa) | Human | ABLIM2 | 1:3~1:6 | Negative | Online Inquiry |
KO24874 | ABLIM2 Knockout cell line (HCT 116) | Human | ABLIM2 | 1:2~1:4 | Negative | Online Inquiry |
ABLIM2 Gene Knockout Cell Lines are specialized genetically modified cell lines in which the ABLIM2 gene has been effectively disrupted or inactivated. This product is at the forefront of gene editing technology, utilizing CRISPR-Cas9 or similar methods to create a controlled environment that allows researchers to investigate the specific roles and effects of the ABLIM2 protein in cellular biology.
The ABLIM2 gene encodes a member of the actin-binding protein family, crucial for processes including cytoskeletal organization, cellular adhesion, and signal transduction. The knockout of this gene provides unique insights into its contributions to various physiological and pathological conditions, including cell migration, proliferation, and potential implications in cancer models. Researchers can employ these cell lines to elucidate the mechanistic pathways influenced by ABLIM2 and assess potential targets for therapeutic intervention.
The scientific importance of ABLIM2 Gene Knockout Cell Lines lies in their versatility for applications ranging from fundamental biology to translational research. They serve as vital tools in the study of gene function, drug discovery, and disease modeling, offering a streamlined approach to dissect complex biological systems.
What sets our knockout cell lines apart from alternatives is the precision of our gene editing technology, which ensures high efficiency and specificity of gene disruption. This minimizes off-target effects, enabling more reliable experimental outcomes. Additionally, our comprehensive validation protocols guarantee the integrity of gene knockout, providing researchers with confidence in their use.
For researchers and clinicians focused on cutting-edge genetic research, ABLIM2 Gene Knockout Cell Lines represent a valuable asset that supports innovation in understanding complex diseases and developing novel therapeutic strategies. Our company is committed to advancing research through high-quality biological products, drawing on extensive expertise in genetic engineering and cell line development. We pride ourselves on delivering robust tools that empower scientific discovery and drive breakthroughs in various biomedical fields.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.